Fact CheckerSign in

NCT01475500Active, not recruiting

Nashville Early Diagnosis Lung Cancer Project

Source: ClinicalTrials.gov · Last updated 12 Dec 2023

Brief summary (registry, in English)

This screening study will address the lack of molecular strategies for the early detection of lung cancer and integrate those with epidemiological and imaging strategies. The hypothesis is that the repeated measure of biomarkers of risk obtained from the molecular analysis of biological specimens including those from bronchoscopy (bronchial brushings and biopsies) may contribute to the refinement of high-risk populations and allow an earlier clinical diagnosis. The goal of the investigators study is to provide screening for lung cancer in a high-risk population. In this prospective cohort it will be tested whether repeated measure of biomarkers of risk allows early detection of lung cancer.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
480 (actual)
First submitted
18 Oct 2011
Start date
1 Apr 2011
Primary completion date
31 Oct 2026
Lead sponsor
Vanderbilt-Ingram Cancer Center
Diseases
Lung cancer
NCT number
NCT01475500

What you commit to

  • Study type: Observational
  • Participants enrolled: 480
  • From 1 Apr 2011 to the primary completion date, 31 Oct 2026
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of diagnosis/treatment of lung cancer in the past 2 years
  • History of head/neck or esophageal cancer in the last 1 year

Lab values

  • Participants in whom stopping anti-platelet or anti-coagulation therapy would have an adverse effect (DVT, mechanical heart valves, unstable coronary syndrome, etc.)

Other

  • Inability to provide informed consent

Who the study is looking for

  • 55 - 80 years of age
  • Current smoker or former smoker. If former smoker, must have quit smoking less than 15 years ago
  • \>/= 30 pack year of smoking history

Age in the registry: 55 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Vanderbilt University, Vanderbilt-Ingram Cancer Center
Coordinator of this site? Confirm its status
NashvilleUnited StatesUnknown status
Veterans Administration
Coordinator of this site? Confirm its status
NashvilleUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.